FIVE PRIME THERAPEUTICS INC (FPRX) is a publicly traded company in the Unknown sector. Across all available filings, 29 corporate insiders have executed 425 transactions totaling $200.0M, demonstrating a bearish sentiment with -$158.1M in net insider flow. The most recent transaction on Apr 16, 2021 involved a transaction of 68,971 shares valued at $2.6M.
No significant insider buying has been recorded for FPRX in the recent period.
No significant insider selling has been recorded for FPRX in the recent period.
Based on recent SEC filings, insider sentiment for FPRX is bearish with an Insider Alignment Score of 10/100 and a net flow of -$158.1M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at FIVE PRIME THERAPEUTICS INC (FPRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 29 insiders are actively trading FPRX stock, having executed 425 transactions in the past 90 days. The most active insider is Value Fund L. P. Biotechnology (Executive), who has made 6 transactions totaling $153.1M.
Get notified when executives and directors at FPRX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Apr 16, 2021 | Civik Thomas | Executive | Disposition | 68,971 | $38.00 | $2.6M | Large |
| Apr 16, 2021 | M. Berger Franklin | Executive | Disposition | 5,000 | $38.00 | $190.0K | |
| Apr 16, 2021 | White David | Executive | Disposition | 33,423 | $38.00 | $1.3M | Large |
| Apr 16, 2021 | Louise Collins Helen | Executive | Disposition | 135,547 | $38.00 | $5.2M | Large |
| Apr 16, 2021 | Louise Collins Helen | Executive | Award | 66,000 | $N/A | $0 | |
| Apr 16, 2021 | Smith David V | Executive | Disposition | 138,947 | $38.00 | $5.3M | Large |
| Apr 16, 2021 | Smith David V | Executive | Award | 66,000 | $N/A | $0 | |
| Apr 16, 2021 | Willard Sarena Francis | Executive | Disposition | 795 | $38.00 | $30.2K | |
| Apr 16, 2021 | Willard Sarena Francis | Executive | Disposition | 795 | $38.00 | $30.2K | |
| Apr 16, 2021 | Willard Sarena Francis | Executive | Disposition | 795 | $38.00 | $30.2K | |
| Apr 16, 2021 | Willard Sarena Francis | Executive | Disposition | 169,468 | $38.00 | $6.4M | Large |
| Apr 16, 2021 | Willard Sarena Francis | Executive | Award | 66,000 | $N/A | $0 | |
| Apr 9, 2021 | Civik Thomas | Executive | Payment | 11,088 | $37.94 | $420.7K | |
| Apr 6, 2021 | Willard Sarena Francis | Executive | Gift | 14,174 | $N/A | $0 | |
| Apr 5, 2021 | R. Ringo William | Executive | Gift | 10,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 76 | $179.1M | 73.6% |
Disposition(D) | 9 | $21.0M | 8.6% |
Purchase(P) | 67 | $21.0M | 8.6% |
Payment(F) | 82 | $15.8M | 6.5% |
Exercise(M) | 111 | $5.5M | 2.3% |
Gift(G) | 16 | $1.0M | 0.4% |
Award(A) | 58 | $0 | 0.0% |
Other(J) | 2 | $0 | 0.0% |
Conversion(C) | 4 | $0 | 0.0% |
Insider selling pressure at FIVE PRIME THERAPEUTICS INC has increased, with 29 insiders executing 425 transactions across all time. Total sales of $179.1M significantly outpace purchases of $21.0M, resulting in a net outflow of $158.1M. This selling activity appears largely discretionary, which may warrant closer attention from investors.